-
<![CDATA[Trodelvy Misses Primary Endpoint in ASCENT-07 Breast Cancer Trial ]]>
07 Nov 2025 23:03 GMT
… HER2-negative metastatic breast cancer, particularly in … Breast Cancer and Treatment Options
HR-positive, HER2-negative metastatic breast cancer … is the most common breast cancer … and require chemotherapy. Standard chemotherapy is …
-
<![CDATA[Sacituzumab Govitecan Misses PFS in First-Line HR+/HER2– Metastatic Breast Cancer]]>
07 Nov 2025 23:44 GMT
… treated with chemotherapy.
“HR+/HER2[–] metastatic breast cancer is a … chemotherapy, including paclitaxel, nab-paclitaxel, or capecitabine.
Sacituzumab Govitecan in Breast Cancer … HR+/HER2-) metastatic breast cancer who have received endocrine therapy …
-
Gilead's Trodelvy stumbles in first-line breast cancer trial, adding to shaky clinical track record
07 Nov 2025 23:56 GMT
… of cytotoxic chemotherapy.
“HR+/HER2-negative metastatic breast cancer is a … previously untreated metastatic triple-negative breast cancer (TNBC) who were not … chemotherapy when used as an initial treatment for metastatic triple-negative breast cancer …
-
Breast Cancer Navigator: Your guide to cancer care at Centralus Health
07 Nov 2025 22:46 GMT
… confuse patients,” says Courtney Irwin, breast cancer navigator at Arnot Health, a … work through your treatment alone. Breast cancer navigators, often medical professionals with … any questions.
Cancer treatments, like chemotherapy, can bring many physical and …
-
UAMS Employee Overcomes Breast Cancer, Highlights Importance of Yearly Mammograms
07 Nov 2025 18:55 GMT
… Nursing, entrusted her breast cancer care to physicians at … 2025 | Treneica McKnight’s breast cancer journey began in February … breast cancer, to form a plan for her treatment.
McKnight began chemotherapy … testing showed that breast cancer is hereditary on her …
-
HER2-Targeted Radioimmunotherapy Yields Complete and Lasting Remission in Breast Cancer Model
07 Nov 2025 17:40 GMT
… HER2-positive breast cancers who have … reducing reliance on chemotherapies and mitigating the … Breast cancer
Tags: Actinium-225 alpha-emitteraggressive breast cancer … subtypesdurable remission in cancer therapyHER2-positive breast cancer …
-
<![CDATA[First-Line Sacituzumab Govitecan After Endocrine Therapy Fails to Improve PFS in HR+/HER2-Negative Breast Cancer ]]>
07 Nov 2025 17:32 GMT
… chemotherapy in patients with hormone receptor–positive, HER2-negative metastatic breast cancer … hybridization) metastatic breast cancer who had … HER2-negative metastatic breast cancer.
Sacituzumab govitecan … ;HER2-) metastatic breast cancer who have received …
-
Ultrasound-triggered chemotherapy to reduce side-effects
07 Nov 2025 21:08 GMT
… diagnosis but also to activate chemotherapy drugs during treatment. This dual … to oncology procedures, such as breast cancer diagnosis and interventions,” Hu notes … physical and emotional toll of chemotherapy, improve patient outcomes and lower …
-
Circuit Weight Training Enhances Quality of Life and Functional Outcomes in Breast Cancer Survivors: A Randomized Controlled Trial
07 Nov 2025 16:14 GMT
… breast cancer sufferers in the US alone.4
Breast cancer … exercise interventions in breast cancer recovery. Circuit Weight … patients with breast cancer during chemotherapy- the critical … interventions’ impact on breast cancer survivors’ functional performance …
-
Gilead's Trodelvy Misses Main Goal In Breast Cancer Study But Shows Early Survival Trend
07 Nov 2025 15:27 GMT
… versus chemotherapy in HR+/HER2-negative metastatic breast cancer patients … were candidates for cytotoxic chemotherapy.
The study did … trend favoring Trodelvy over chemotherapy was observed.
The … consistent with prior Trodelvy breast cancer studies, and no …